drugset / Trial / NCT00334607

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

NCT00334607 ↗

Phase 3 Completed 484 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this this study is to confirm absence of immune interference between HRV vaccine and routine infant vaccinations currently in use in the USA.

Timeline

Start
2006-06
Primary completion
2007-02
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject G1P[8] human rotavirus vaccine Vaccine — Oral

Indications